IP Library › Assignment 069573/0052
Patent Assignment
Reel/Frame 069573/0052

Merger

Recorded: 2024-12-12 Pages: 6
Assignor
EUREKA THERAPEUTICS, INC.
Executed: 2018-03-05
Assignee
EUREKA THERAPEUTICS, INC.
5858 HORTON STREET, SUITE 370, EMERYVILLE, CALIFORNIA, 94608
Covered Properties (3)
Antibody/T-Cell Receptor Chimeric Constructs and Uses Thereof
Application: 16/121,475 →
Publication: US 2019/0022216
Constructs Targeting Histone H3 Peptide/Mhc Complexes and Uses Thereof
Application: 16/477,509 →
Publication: US 2019/0338035
Antibody/T-Cell Receptor Chimeric Constructs and Uses Thereof
Application: 17/716,667 →
Publication: US 2022/0348629
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 13, 2018
From: LU, JINGWEI; YANG, ZHIYUAN; LIU, CHENG; LIU, HONG
To: EUREKA THERAPEUTICS, INC.
Reel/Frame 046866/0151 →
Merger Nov 20, 2018
From: EUREKA THERAPEUTICS, INC.
To: EUREKA THERAPEUTICS, INC.
Reel/Frame 047552/0801 →
Assignment of Assignor's Interest Jul 17, 2019
From: CHAN, VIVIEN WAI-FAN; LIU, HONG; NAKANO, YOKO; XU, YIYANG
To: EUREKA THERAPEUTICS, INC.
Reel/Frame 049779/0944 →
Assignment of Assignor's Interest Apr 8, 2022
From: LU, JINGWEI; YANG, ZHIYUAN; LIU, CHENG; LIU, HONG
To: EUREKA THERAPEUTICS, INC.
Reel/Frame 059551/0124 →
Assignment of Assignor's Interest Apr 8, 2022
From: EUREKA THERAPEUTICS, INC.
To: EUREKA THERAPEUTICS, INC.
Reel/Frame 059551/0168 →